SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001453687-24-000026
Filing Date
2024-01-04
Accepted
2024-01-04 17:08:06
Documents
5
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1704406063.html 4  
1 FORM 4 wk-form4_1704406063.xml 4 5817
2 EX-24.1 poajewell.htm EX-24.1 5534
3 poajewell001.jpg GRAPHIC 257267
4 poajewell002.jpg GRAPHIC 95968
5 poajewell003.jpg GRAPHIC 38551
  Complete submission text file 0001453687-24-000026.txt   552729
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Issuer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARTESIAN THERAPEUTICS, INC. 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address
Jewell Christopher M (Reporting) CIK: 0002000226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37798 | Film No.: 24513137